Gamble Jones Investment Counsel’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $781K | Sell |
10,053
-300
| -3% | -$24.3K | 0.06% | 125 |
|
|
2022
Q3 | $836K | Sell |
10,353
-405
| -4% | -$36.4K | 0.07% | 116 |
|
|
2022
Q2 | $966K | Buy |
10,758
+2,755
| +34% | +$279K | 0.07% | 111 |
|
|
2022
Q1 | $888K | Sell |
8,003
-1,284
| -14% | -$136K | 0.06% | 126 |
|
|
2021
Q4 | $961K | Buy |
9,287
+50
| +0.5% | +$5.79K | 0.06% | 122 |
|
|
2021
Q3 | $1.16M | Buy |
9,237
+101
| +1% | +$13.1K | 0.08% | 111 |
|
|
2021
Q2 | $1.13M | Sell |
9,136
-1,000
| -10% | -$126K | 0.07% | 113 |
|
|
2021
Q1 | $1.2M | Buy |
10,136
+45
| +0.4% | +$5.27K | 0.08% | 113 |
|
|
2020
Q4 | $1.18M | Sell |
10,091
-2,148
| -18% | -$236K | 0.08% | 113 |
|
|
2020
Q3 | $1.27M | Buy |
12,239
+536
| +5% | +$53.8K | 0.09% | 102 |
|
|
2020
Q2 | $1.07M | Buy |
11,703
+850
| +8% | +$81.5K | 0.09% | 105 |
|
|
2020
Q1 | $979K | Hold |
10,853
| – | – | 0.09% | 107 |
|
|
2019
Q4 | $1.23M | Sell |
10,853
-275
| -2% | -$30.2K | 0.1% | 112 |
|
|
2019
Q3 | $1.21M | Sell |
11,128
-399
| -3% | -$41.6K | 0.1% | 107 |
|
|
2019
Q2 | $1.12M | Buy |
11,527
+1,477
| +15% | +$135K | 0.1% | 115 |
|
|
2019
Q1 | $915K | Buy |
10,050
+1
| +0% | +$90 | 0.08% | 124 |
|
|
2018
Q4 | $914K | Sell |
10,049
-1,598
| -14% | -$149K | 0.09% | 119 |
|
|
2018
Q3 | $1.15M | Buy |
11,647
+2,965
| +34% | +$274K | 0.11% | 118 |
|
|
2018
Q2 | $743K | Sell |
8,682
-158
| -2% | -$13.2K | 0.07% | 136 |
|
|
2018
Q1 | $709K | Buy |
8,840
+1,501
| +20% | +$124K | 0.07% | 143 |
|
|
2017
Q4 | $593K | Sell |
7,339
-85
| -1% | -$6.81K | 0.06% | 150 |
|
|
2017
Q3 | $577K | Buy |
7,424
+1
| +0% | +$83 | 0.06% | 151 |
|
|
2017
Q2 | $659K | Sell |
7,423
-122
| -2% | -$10.3K | 0.07% | 148 |
|
|
2017
Q1 | $608K | Sell |
7,545
-4,097
| -35% | -$320K | 0.06% | 151 |
|
|
2016
Q4 | $829K | Buy |
11,642
+2
| +0% | +$157 | 0.09% | 135 |
|
|
2016
Q3 | $1.01M | Sell |
11,640
-304
| -3% | -$26.5K | 0.11% | 121 |
|
|
2016
Q2 | $1.04M | Sell |
11,944
-254
| -2% | -$20.5K | 0.11% | 120 |
|
|
2016
Q1 | $915K | Sell |
12,198
-164
| -1% | -$12.4K | 0.1% | 124 |
|
|
2015
Q4 | $951K | Sell |
12,362
-65
| -0.5% | -$4.89K | 0.11% | 121 |
|
|
2015
Q3 | $832K | Sell |
12,427
-822
| -6% | -$60.5K | 0.1% | 134 |
|
|
2015
Q2 | $982K | Sell |
13,249
-999
| -7% | -$76.3K | 0.1% | 129 |
|
|
2015
Q1 | $1.11M | Buy |
14,248
+180
| +1% | +$13.6K | 0.12% | 122 |
|
|
2014
Q4 | $1.02M | Buy |
14,068
+3
| +0% | +$208 | 0.11% | 127 |
|
|
2014
Q3 | $871K | Buy |
14,065
+12
| +0.1% | +$763 | 0.1% | 128 |
|
|
2014
Q2 | $896K | Buy |
14,053
+4,012
| +40% | +$244K | 0.1% | 132 |
|
|
2014
Q1 | $618K | Sell |
10,041
-1,785
| -15% | -$104K | 0.07% | 149 |
|
|
2013
Q4 | $679K | Sell |
11,826
-13
| -0.1% | -$737 | 0.08% | 143 |
|
|
2013
Q3 | $630K | Buy |
11,839
+16
| +0.1% | +$861 | 0.08% | 144 |
|
|
2013
Q2 | $609K | Buy |
+11,823
| New | +$584K | 0.08% | 145 |
|
Other funds holding MDT
Gamble Jones Investment Counsel's MDT Position: Q4 2022 in Review
Gamble Jones Investment Counsel reduced its Medtronic (MDT) stake by 2.9% in Q4 2022, selling an estimated $24.3K and leaving 10,053 shares worth $781K. The position accounts for 0.06% of the portfolio, ranked #125.
Gamble Jones Investment Counsel first reported a position in MDT in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.27M in Q3 2020. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.
- Gamble Jones Investment Counsel held 10,053 shares of Medtronic worth $781K as of Q4 2022.
- Gamble Jones Investment Counsel sold 300 Medtronic shares in Q4 2022, an estimated $24.3K.
- Medtronic made up 0.06% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #125 holding.
- Gamble Jones Investment Counsel first reported a position in Medtronic in Q2 2013 and has held it in 39 quarters since.
- Gamble Jones Investment Counsel's Medtronic position peaked at $1.27M in Q3 2020.
- 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.
Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.